Show Summary Details
Page of

Women in Clinical Trials 

Women in Clinical Trials
Chapter:
Women in Clinical Trials
Author(s):

Jeanne E. Poole

DOI:
10.1093/med/9780199321971.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 October 2019

Women have been underrepresented in every major randomized clinical trial examining arrhythmia management in patients with advanced cardiovascular disease. In 1986, the National Heart, Lung, and Blood Institute established a policy encouraging the inclusion of women in clinical trials. The mandate to include women in clinical research became public law through a section in the National Institutes of Health (NIH) Revitalization Act of 1993. The NIH Department of Health and Human Services established the Office of Research on Women’s Health in 1990. The goal of this office is to promote research on women’s health and sex differences in NIH-funded studies and to promote and partner with women’s health research in studies funded through alternate agencies and sources. Important in this effort is a mandate to provide sex-specific results and communicate the results of women’s health research to the public.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.